June 18, 2015 | Lumenis, the developer of medical software tools in a number of fields, will be acquired by XIO Group for a total of $510 million, at a value of $14 per share. Goldman Sacs advised the deal for the Israeli company and Morgan Stanley for the Chinese investment firm XIO Group. Lumenis is headquartered in Yokneam, Israel and is headed by CEO Tzipi Ozer-Armon.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments